6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

17 trials found

diseases per page:

Showing 1 to 10 of 17 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04117178 (ClinicalTrials.gov)	February 4, 2020	30/9/2019	Monitoring Anti-Dementia Drugs by Serum Levels	Monitoring Anti-Dementia Drugs by Serum Levels: Importance of Serum Levels, Drug-monitoring, Side-ef ...	Dementia;Dementia With Lewy Bodies;Dementia in Parkinsons Disease;Dementia Alzheimers;Alzheimer Dise ...	Drug: Donepezil;Drug: Memantine;Diagnostic Test: Measurement of serum level of anti-dementia drug	Zealand University Hospital	Epilepsihospitalet Filadelfia	Recruiting	18 Years	N/A	All	110	Phase 4	Denmark
2	NCT03858270 (ClinicalTrials.gov)	April 1, 2019	2/10/2018	Inhibition of a-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine	Inhibition of a-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine	Parkinson Disease	Drug: Memantine;Other: Placebo	Wayne State University	NULL	Recruiting	45 Years	85 Years	All	50	Phase 3	United States
3	EUCTR2017-002707-10-DK (EUCTR)	10/04/2018	03/11/2017	Measurements of drug concentration in the blood for anti-dementia drugs, in order to improve efficac ...	Serum-monitoring of anti-dementia drugs, and the relevance to side-effects, clinical efficacy and co ...	Dementia in Alzheimers Disease, Parkinsons Disease and Dementia with Lewy Bodies MedDRA version: 20. ...	Trade Name: Memantin Orion INN or Proposed INN: MEMANTINE Product Name: Donepezil Sandoz Product Code: 2 ...	Regional Dementia Research Centre, Dept of Neurology	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	110	Phase 4	Denmark
4	JPRN-UMIN000010596	2013/05/01	01/05/2013	Randomized crossover trial comparing memantineor amantadine for Parkinson's disease with motor fluct ...		Parkinson's disease	Memantinepreceding arm Titrate the memantine, administered for 3 months. And tapering memantineand am ...	Department of Neurology, Juntendo University School of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male	40	Not selected	Japan
5	NCT01108029 (ClinicalTrials.gov)	October 2009	20/7/2009	Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease	Study of Memantineto Treat Gait Disorders And Attention Deficit In Parkinson's Disease: A Randomized ...	Parkinson's Disease;Gait Disorders, Neurologic	Drug: memantine;Drug: placebo	University Hospital, Lille	NULL	Completed	30 Years	80 Years	Both	28	Phase 4	France
6	EUCTR2005-002038-36-GR (EUCTR)	27/02/2007	09/10/2006	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	Patients with Parkinson’s disease dementia or dementia with Lewy Bodies MedDRA version: 8.1;Level: L ...	Trade Name: Ebixa Product Name: Ebixa INN or Proposed INN: MEMANTINE HYDROCHLORIDE Trade Name: Ebixa Prod ...	H. Lundbeck A/S	NULL	Not Recruiting			Female: yes Male: yes	200	Phase 3	France;Greece;Spain;Austria;Germany;Italy;United Kingdom
7	NCT00855686 (ClinicalTrials.gov)	January 2007	3/3/2009	Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies	A Randomised, Double-blind, Placebo-controlled, 6-month Study of the Efficacy and Safety of Memantin ...	Parkinson's Disease Dementia;Dementia With Lewy Bodies	Drug: Memantine;Drug: Placebo	H. Lundbeck A/S	NULL	Completed	50 Years	N/A	Both	199	Phase 4	Germany
8	EUCTR2005-002038-36-FR (EUCTR)	01/12/2006	24/08/2010	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	Patients with Parkinson’s disease dementia or dementia with Lewy Bodies	Trade Name: Ebixa Product Name: Ebixa INN or Proposed INN: MEMANTINE HYDROCHLORIDE Trade Name: Ebixa Prod ...	H. Lundbeck A/S	NULL	Not Recruiting			Female: yes Male: yes	200	Phase 3	France;Greece;Spain;Austria;Germany;Italy;United Kingdom
9	EUCTR2005-002038-36-DE (EUCTR)	29/11/2006	19/01/2007	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	Patients with Parkinson’s disease dementia or dementia with Lewy Bodies	Trade Name: Ebixa Product Name: Memantine INN or Proposed INN: MEMANTINE HYDROCHLORIDE Product Name: Mem ...	H. Lundbeck A/S	NULL	Not Recruiting			Female: yes Male: yes	200		United Kingdom;Germany;France;Spain;Italy;Greece;Austria
10	EUCTR2005-002038-36-GB (EUCTR)	31/10/2006	09/10/2006	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantin ...	Patients with Parkinson’s disease dementia or dementia with Lewy Bodies MedDRA version: 8.1;Level: L ...	Trade Name: Ebixa Product Name: Ebixa INN or Proposed INN: MEMANTINE HYDROCHLORIDE Product Code: Lu 00-8 ...	H. Lundbeck A/S	NULL	Not Recruiting			Female: yes Male: yes	200	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Greece;Spain;Austria;Germany;Italy;United Kingdom

First Previous1 2Next Last